Drug nearly doubles survival rate for some pancreatic cancer patients, study finds
Summary
A new drug has been found to nearly double the survival rate for some patients with pancreatic cancer, according to recent research. Experts at the MGB Cancer Institute shared information about this medical breakthrough.Key Facts
- The new drug targets pancreatic cancer.
- Some patients who used the drug lived almost twice as long as before.
- The research was presented by Dr. Harsh Singh from the MGB Cancer Institute.
- This finding suggests new hope for pancreatic cancer treatment.
- Pancreatic cancer is known for being difficult to treat.
- The study results were shared on CBS News.
- More details are available through the CBS News app.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.